MedPath

Rebiotix Inc.

Rebiotix Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

Phase 3
Completed
Conditions
Infection
Clostridium Difficile Infection
Communicable Diseases
Interventions
First Posted Date
2019-04-30
Last Posted Date
2024-08-07
Lead Sponsor
Rebiotix Inc.
Target Recruit Count
793
Registration Number
NCT03931941
Locations
🇺🇸

Phoenix, Phoenix, Arizona, United States

🇺🇸

North Little Rock, North Little Rock, Arkansas, United States

🇺🇸

Oxnard, Oxnard, California, United States

and more 47 locations

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

Phase 3
Completed
Conditions
Clostridium Difficile Infection (CDI)
Interventions
Drug: Placebo
Drug: Open label RBX2660 (only for confirmed CDI recurrence)
First Posted Date
2017-08-09
Last Posted Date
2024-07-10
Lead Sponsor
Rebiotix Inc.
Target Recruit Count
320
Registration Number
NCT03244644
Locations
🇺🇸

Athens, Athens, Alabama, United States

🇺🇸

Dothan, Dothan, Alabama, United States

🇺🇸

Phoenix, Phoenix, Arizona, United States

and more 59 locations

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Phase 2
Completed
Conditions
Clostridium Difficile Infection
Interventions
Biological: RBX2660
Drug: Standard of Care Antibiotics
First Posted Date
2015-10-28
Last Posted Date
2021-03-26
Lead Sponsor
Rebiotix Inc.
Target Recruit Count
272
Registration Number
NCT02589847

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Phase 2
Completed
Conditions
Enterocolitis Clostridium Difficile Recurrent
First Posted Date
2014-11-24
Last Posted Date
2021-01-15
Lead Sponsor
Rebiotix Inc.
Target Recruit Count
150
Registration Number
NCT02299570
Locations
🇺🇸

Mayo Clinic Arizona, Phoenix, Arizona, United States

🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

Borland-Groover Clinic, Jacksonville, Florida, United States

and more 18 locations

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Phase 2
Completed
Conditions
Recurrent Clostridium Difficile Infection
First Posted Date
2013-08-19
Last Posted Date
2019-11-13
Lead Sponsor
Rebiotix Inc.
Target Recruit Count
34
Registration Number
NCT01925417
Locations
🇺🇸

Mayo Clinic Arizona, Phoenix, Arizona, United States

🇺🇸

Denver Health and University of Colorado, Denver, Colorado, United States

🇺🇸

Borland-Groover Clinic, Jacksonville, Florida, United States

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath